The induction ceremony is scheduled for May 27, 2024, during the World Biomaterials Congress (WBC2024) in Daegu, South Korea.
Expressing his gratitude for this remarkable achievement, Keselowsky remarked, “I am profoundly grateful for the honor of becoming an FBSE. This recognition is the culmination of years of dedicated work advancing the biomaterials domain. My heartfelt thanks go to my students, academic mentors and collaborators, and the biomaterials and BME community.”
As a full professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida, Keselowsky’s research is at the forefront of engineering biomaterial-cell interactions and immune engineering.
Immune cells play a pivotal role in the body’s response to biomaterials upon implantation. Keselowsky’s laboratory is dedicated to advancing the fundamental understanding of immune cell interactions with biomaterials and the engineering the orchestration of immunological processes. This work holds wide-ranging implications in fields such as implanted devices, therapeutic vaccines, tissue engineering, and combination products.